Fredun Pharmaceuticals Ltd.

FREDUN

₹1564.0

1.01% (15.7)

Market Cap

₹732 Cr.

P/E

37.11

Key Ratios

Edit Ratio's

Market cap

732 Cr

37.11

Prom Holding

48.93 %

ROE (%)

12.86

ROCE (%)

24.94

Div Yield (%)

0.05

Sales

497 Cr

OPM (%)

12.39 %

Debt to Equity

1.18

Edit Ratio's

About

Fredun Pharmaceuticals Limited is engaged in manufacturing of pharmaceutical products. The com… Read more

Low

635

52W Range

High

1785

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
ROE

Roe has decreased vs 10 year trend
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Fredun Pharmaceuticals Ltd. Business

What does Fredun Pharma do?

Fredun Pharmaceuticals Limited is a trusted manufacturer of pharmaceutical products, dietary supplements, nutraceuticals, and healthcare products in Africa, Southeast Asia, CIS countries, and Latin America, aiming to be a holistic healthcare provider.

Who are the competitors of Fredun Pharma?

Fredun Pharma major competitors are Shivalik Rasayan, Kilitch Drugs(India), Ind-Swift Lab., Bharat Parenterals, Prevest Denpro, Venus Remedies, Anuh Pharma.
Market Cap of Fredun Pharma is ₹732 Crs.
While the median market cap of its peers are ₹719 Crs.

Is Fredun Pharma financially stable compared to its competitors?

Fredun Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Fredun Pharma is 3.14 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Jul	Mar Dec	Mar	Mar Jun Sep Dec	Sep
Investor Presentation	Jun			Dec	Dec		Mar
Conference Call	Jun
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Fredun Pharmaceuticals Ltd.

Corporate Governance Issues - Fredun Pharma - Leading Nowhere

Interaction with Fredun Pharmaceuticals - Corporate Capital Ventures

Pharmaceuticals

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Fredun Pharmaceuticals Ltd.

Fredun Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

8 Yes

1 Neutral

7 No

1 No Data

Accounting & Shareholding

Other Income

Pledge

Revenue Recognition

Depreciation Effect

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

Capex vs ROCE

Current vs Historic Valuation

Sales Growth

Balance Sheet Strength

ROE

Debt

Share price

Working Capital

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

Corporate Actions

FAQs on Fredun Pharmaceuticals Ltd. Business

What does Fredun Pharma do?

Who are the competitors of Fredun Pharma?

Is Fredun Pharma financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE